| Literature DB >> 27694349 |
Dhruv S Kazi1,2, P Gregg Greenough3, Rishi Madhok4, Aaron Heerboth5, Ahmed Shaikh6, Jennifer Leaning7,8, Satchit Balsari7,8,9.
Abstract
Background: Planning for mass gatherings often includes temporary healthcare systems to address the needs of attendees. However, paper-based record keeping has traditionally precluded the timely application of collected clinical data for epidemic surveillance or optimization of healthcare delivery. We evaluated the feasibility of harnessing ubiquitous mobile technologies for conducting disease surveillance and monitoring resource utilization at the Allahabad Kumbh Mela in India, a 55-day festival attended by over 70 million people.Entities:
Keywords: Kumbh Mela; mHealth; mass gatherings; mobile phones; primary care; tablet; user-centered design
Mesh:
Year: 2017 PMID: 27694349 PMCID: PMC5939834 DOI: 10.1093/pubmed/fdw091
Source DB: PubMed Journal: J Public Health (Oxf) ISSN: 1741-3842 Impact factor: 2.341
Fig. 1Outpatients await their turn to see a physician at a sector hospital at the Kumbh Mela.
Fig. 2User-centred design for mobile technology at mass gatherings.
Demographics and clinical presentation
| All hospitals | Central hospital | Sector hospital | ||
|---|---|---|---|---|
| Total outpatients | 49 131 | 10 005 | 39 126 | – |
| Age, mean (SD) | 44.7 (19.8) | 34.6 (19.8) | 47.4 (18.9) | <0.001 |
| Age of adult patients, mean (SD) | 48.6 (16.5) | 42.5 (14.7) | 49.9 (16.6) | <0.001 |
| Percentage female, % (SE) | 30.0 (0.2) | 49.5 (0.5)[ | 24.9 (0.2) | <0.001 |
| Proportion paediatric patients, age ≤16 years, % (SE) | 9.5 (0.13) | 22.2 (0.42) | 6.2 (0.12) | <0.001 |
| Musculoskeletal pain, % (SE) | 19.00 (0.18) | 19.17 (0.39) | 18.96 (0.19) | 0.636 |
| Fever, % (SE) | 17.28 (0.17) | 14.53 (0.35) | 17.98 (0.19) | <0.001 |
| Cough, % (SE) | 16.51 (0.17) | 11.20 (0.31) | 17.87 (0.19) | <0.001 |
| Coryza, % (SE) | 16.49 (0.17) | 11.52 (0.32) | 17.77 (0.19) | <0.001 |
| Diarrhoea, % (SE) | 5.35 (0.10) | 3.94 (0.19) | 5.71 (0.12) | <0.001 |
| Abdominal pain, % (SE) | 4.81 (0.10) | 3.87 (0.19) | 5.05 (0.11) | <0.001 |
| Cardiopulmonary, % (SE) | 30.36 (0.21) | 20.59 (0.40) | 32.86 (0.24) | <0.001 |
| Musculoskeletal, % (SE) | 19.21 (0.18) | 19.97 (0.40) | 19.02 (0.20) | 0.033 |
| Gastrointestinal, % (SE) | 4.60 (0.37) | 11.26 (0.32) | 15.87 (0.18) | <0.001 |
| Skin and soft tissues, % (SE) | 4.49 (0.09) | 5.74 (0.23) | 4.18 (0.10) | <0.001 |
| Genitourinary, % (SE) | 0.99 (0.04) | 3.5 (0.18) | 0.33 (0.02) | <0.001 |
SD, standard deviation; SE, standard error.
aWomen constituted 18% of patients at the central hospital after excluding the women's health clinic, which served as a primary care clinic for women.
bProportion of patients presenting with stated complaint.
cProportion of patients presenting with one or more complaints related to stated organ system.
Fig. 3Disease trends (study data).
Fig. 4Daily number of outpatient visits (official data).
Diagnostic studies and prescriptions
| All hospitals | Central hospital | Sector hospitals | ||
|---|---|---|---|---|
| Total outpatients | 49 131 | 10 005 | 39 126 | – |
| X-ray, % (SE) | 0.37 (0.02) | 1.93 (0.13) | 0.00 (0.00) | <0.001 |
| Ultrasound, % (SE) | 0.01 (0.00) | 0.04 (0.02) | 0.00 (0.00) | <0.001 |
| One or more prescriptions given, % (SE) | 86.69 (0.15) | 69.72 (0.46) | 91.03 (0.14) | <0.001 |
| Antimicrobial, % (SE) | 31.85 (0.21) | 29.77 (0.46) | 32.39 (0.24) | <0.001 |
| Acetaminophen, % (SE) | 30.79 (0.21) | 28.72 (0.45) | 31.32 (0.23) | <0.001 |
| Non-steroidal anti-inflammatory agents, % (SE) | 28.43 (0.20) | 24.89 (0.43) | 29.34 (0.23) | <0.001 |
| Antihistamines, % (SE) | 26.19 (0.20) | 16.75 (0.37) | 28.61 (0.23) | <0.001 |
| Supplements—vitamins and minterals, % (SE) | 25.23 (0.20) | 23.09 (0.42) | 25.77 (0.22) | <0.001 |
| Vitamins, % (SE) | 19.17 (0.18) | 19.40 (0.40) | 19.11 (0.20) | 0.516 |
| Minerals—calcium and iron, % (SE) | 12.68 (0.15) | 12.62 (0.33) | 12.70 (0.17) | 0.843 |
| Gastroprotectives—PPI, H2 blocker, antacids, % (SE) | 11.52 (0.14) | 9.24 (0.29) | 12.10 (0.16) | <0.001 |
| Anti-parasitic % (SE) | 6.13 (0.11) | |||
| Bronchodilators, % (SE) | 2.69 (0.07) | 1.32 (0.11) | 3.04 (0.09) | <0.001 |
| Steroids, % (SE) | 0.50 (0.03) | 0.87 (0.09) | 0.41 (0.03) | <0.001 |
| Referral to specialty clinic, % (SE) | 0.06 (0.04) | 2.97 (0.17) | 0.00 (0.51) | <0.001 |
| Inpatient admission, % (SE) | 1.20 (0.05) | 0.54 (0.07) | 1.38 (0.05) | <0.001 |
SE, standard error.
aReported as proportion of patients receiving one or more prescriptions for the stated drug class.